Search Within

James Joseph Harding

  1. "Neal Rosen"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. Breast Medicine Service (5)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Gastrointestinal Oncology Service (5)
  5. Human Oncology and Pathogenesis Program (5)
  6. Melanoma and Immunotherapeutics Service (5)

More Groups

People
  1. Neal Rosen (5)
  2. David Solit (4)
  3. Paul Chapman (4)
  4. Taha Merghoub (4)
  5. Donavan Cheng (3)
  6. Margaret Callahan (3)

More People

Years
  1. 2022 (1)
  2. 2017 (1)
  3. 2015 (1)
  4. 2014 (1)
  5. 2012 (1)
Publications
  1. Cancer Discovery (1)
  2. JCO Precision Oncology (1)
  3. Journal of Clinical Oncology (1)
  4. New England Journal of Medicine (1)
  5. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Massachusetts Medical Society (1)
  4. Oxford University Press (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • A retrospective evaluation of vemurafenib as treatment for BRAF-mutant melanoma brain metastases
    Journal Article

    Harding, J. J.; Catalanotti, F.; Munhoz, R. R.; Cheng, D. T.; Yaqubie, A.; Kelly, N.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Lacouture, M. E.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies
    Journal Article

    Abdel-Wahab, O.; Klimek, V. M.; Gaskell, A. A.; Viale, A.; Cheng, D.; Kim, E.; Rampal, R.; Bluth, M.; Harding, J. J.; Callahan, M. K.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Progression of RAS-mutant leukemia during RAF inhibitor treatment
    Journal Article

    Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save